Assessment of prolonged proteasome inhibition through ixazomib‐based oral regimen on newly diagnosed and first‐relapsed multiple myeloma: A real‐world Chinese cohort study
Article in Cancer Medicine (April 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Article in Cancer Medicine (April 2024)
Article in Future Oncology (January 2024)
Article in Reactions Weekly (October 2023)